
Merlintrader Trading Pub
Biotech catalyst, news and analysis PDUFA tracker

Merlintrader Trading Pub
Biotech catalyst, news and analysis PDUFA tracker
AI transparency: articles and reports are produced with the help of artificial intelligence and checked through a process that does not constitute specialist validation. They may contain errors: verify relevant information with independent sources. Read the full disclaimer.
Nov 16, 2026
POET Technologies reported revenue of $1,026,087 for the three months ended September 30, 2026, with cash and cash equivalents of $276,018,170.
Nasdaq: $POETPhotonics · AI optical interconnectsProduction ramp under way2026 engine target moved to Q2 2027~13% of shares short
POET Stock Hub: POET Technologies News, Lumilens Order and the Path to Revenue
POET Technologies reported record third-quarter revenue of $1.03 million on November 16, 2026, its seventh consecutive quarter of sequential growth, and ended September with $774.3 million of cash and short-term investments. The same report moved the 30,000 optical engines originally targeted for 2026 into a backlog the company now expects to ship by the second quarter of 2027, citing supply tightening and a yield ramp. The $50 million Lumilens order still depends on qualification and a 2027 ramp; the next dated test is the fourth-quarter report and first quarterly conference call on March 1, 2027.
Full research report · PDF
POET Technologies ($POET) research report, as of November 16, 2026
24 pages: scenarios, the Lumilens order and its warrant, other orders, the third-quarter 2026 results and the September 30 financial statements, cash and monthly burn, manufacturing capacity and the 30,000-engine target moved to the second quarter of 2027, debt and strategic assets, financing, warrants, ownership, short interest, legal matters, sources and FAQ. Available in the Merlintrader Research Library. The report is a dated snapshot and is not updated after that date; this page follows the current situation. For personal use only: redistribution prohibited.
Next catalyst
March 1, 2027 · fourth-quarter and full-year 2026 results · first quarterly conference call
POET will report its fourth-quarter and full-year 2026 results on March 1, 2027 and host its first quarterly conference call that day; from those results it will report as a U.S. domestic issuer, with financial statements prepared under U.S. GAAP. In its November 2 release the company said Giovanni M. Pacelli, appointed Chief Financial Officer that day, will take part in the calls alongside members of the executive leadership team. Before then, POET expects fourth-quarter shipments to exceed its total shipments for the first three quarters of 2026, and the first Lumilens products are on schedule for verification this year, according to the November 16 release. Company release of November 16, 2026
Completed: on November 16, 2026 POET reported third-quarter revenue of $1,026,087, up 80% from the second quarter and 244% from a year earlier, a net loss of $7.6 million, or $0.04 per share, and $12.7 million of cash used in operations (results release · September 30 financial statements). A $1 million installment to Sanan was due on October 31, 2026, under the terms for buying the remaining interest in Super Photonics; the September 30 statements, which predate the due date, still list it in the payment schedule, and as of November 16, 2026 the payment is not confirmed by a company release or filing. On November 2, 2026, POET named Giovanni M. Pacelli Senior Vice President and Chief Financial Officer, succeeding Thomas Mika (company release).
November 6 research update: POET appoints Giovanni Pacelli CFO and changes investor communications
Effective November 2, 2026: POET Technologies appointed Giovanni M. Pacelli Senior Vice President and Chief Financial Officer, succeeding Thomas Mika after ten years in that role. Mika remains with POET until December 2 to support the transition. Pacelli joins from Silicon Labs, where he held a senior finance role, and previously worked in finance functions at Freescale Semiconductor and NXP. POET highlighted his semiconductor-sector experience, capital allocation and investor communications as the company prepares to scale optical-engine and light-source production.
Reporting cadence: POET confirmed November 16, 2026 as the date for its third-quarter results. The company plans to introduce regular quarterly earnings conference calls beginning with the fourth-quarter and full-year 2026 results, with Pacelli participating. This is a change in disclosure practice, not evidence of a new customer order, higher shipment volume or revenue recognition.
Share-based compensation: Pacelli was granted 384,615 restricted share units (RSUs) under the 2025 Omnibus Incentive Plan, with one-third scheduled to vest on each of the first three anniversaries. Vesting and share settlement may affect future dilution, but an RSU grant is not a cash capital raise and should not be added to current shares as though every unit were already vested.
Operational tests remain unchanged: The $50 million Lumilens customer order, manufacturing qualification and 2027 volume-production expectations depend on customer acceptance, equipment capacity, delivery and actual receipts. The CFO change may support execution and disclosure quality but cannot establish those outcomes. Official company announcement, November 2, 2026 · SEC Form 6-K, November 2, 2026.
POET stock at a glance
Stock price · live
Real-time price, volume and moving averages for $POET on JC Just Charts.
Cash + short-term · Sep 30
$774.3M
$276.0M cash and equivalents and $498.4M of bank investment certificates; $796.3M at June 30.
Revenue · September quarter
$1.026M
Up 80% from $569,925 in the June quarter and 244% year on year; $2.10M in nine months.
Operating loss · September quarter
−$18.8M
Net loss $7.6M, or $0.04 a share, after a $6.4M non-cash warrant gain and $5.1M of other income, mainly interest.
Operating cash use · Q3
$12.7M
Against $12.2M in Q2. The new engine line is expected to cost more than $45M, with equipment installed through about April 2027.
Warrants outstanding
78.7M
78,729,968 against 174,215,937 shares at September 30 and November 16, 2026; Lumilens warrants included, 2.29M of them vested. 9.35M have exercise prices of $1.09 to $5.00.
Short interest · Oct 30
13.3%
23,073,693 shares, 3.2 days to cover on Nasdaq figures.
Where POET Technologies stands now
POET designs optical engines, light sources and optical modules for AI systems and data centers, built on its Optical Interposer platform. It is funded but not yet a production business. In the third quarter of 2026 revenue reached a record $1,026,087, from non-recurring engineering services and product sales, up 80% from the second quarter and 244% from a year earlier. The operating loss was $18.8 million and the net loss $7.6 million, or $0.04 per share, after a $6.4 million non-cash gain on the revaluation of warrants and $5.1 million of other income, mainly interest. Operations used $12.7 million in the quarter, against $12.2 million in the second, and cash and short-term investments were $774.3 million at September 30, 2026, against $796.3 million at June 30. Shares outstanding were 174,215,937 at September 30 and November 16, 2026. Third-quarter results, November 16, 2026 · Financial statements, September 30, 2026 · Management discussion and analysis
The report also reset the shipment timetable. POET now expects to ship its current backlog of optical engines, including the 30,000 engines it had targeted for 2026, by the second quarter of 2027; Chairman and CEO Suresh Venkatesan cited supply-chain tightening, wafer and component shortages and the yield ramp of a new production technology. The company says it has secured roughly ten times its wafer capacity at its foundry partner in Malaysia, from about 120 wafers a month for much of 2026 to tools committed for about 1,250, and is building a new engine assembly line in Penang, with total investment expected above $45 million, equipment installed through about April 2027 and manufacturing readiness targeted for mid-2027. It reports nine active customers across 16 projects, seven of them expected to enter production with POET engines in 2027, four customers with orders above $1 million each and, after the quarter, a first purchase order from another Tier 1 laser manufacturer. Blazar hybrid-laser sampling is expected in the first half of 2027, with production targeted for early 2028. These are company expectations: production timing depends on customers qualifying POET engines within their own modules. Company release, November 16, 2026
On November 2, 2026 the company appointed Giovanni M. Pacelli Senior Vice President and Chief Financial Officer, effective that day. He succeeds Thomas Mika, CFO for the past ten years, who stays with the company until December 2, 2026 to support the transition. According to the company, Pacelli joins from Silicon Labs, where he was Senior Director of Finance and spent more than eight years in financial analysis, strategic planning and investor relations; earlier he worked at the chipmakers Freescale Semiconductor and NXP. The release also discloses a grant to Pacelli of 384,615 restricted share units, vesting in equal thirds on the first, second and third anniversaries of the grant, and says the company intends to hold a quarterly earnings conference call starting with the fourth-quarter and full-year 2026 results, with Pacelli participating alongside members of the executive leadership team. Chairman and CEO Suresh Venkatesan said Pacelli will play a central role as POET broadens its engagement with the investment community. Company release, November 2, 2026 · SEC Form 6-K, Exhibit 99.1
The main risk: the headline orders are larger than the revenue they have produced so far. The $50 million Lumilens order is the first step of a framework that could exceed $500 million over five years, but the company ties its revenue to “the successful development and ultimate qualification of the modules, as well as the successful scaling of manufacturing capability”. On November 16, 2026 the company said the first Lumilens products were in the assembly development phase and on schedule for verification this year, with the production ramp aligned to hyperscaler deployments in 2027. In April, all purchase orders from Celestial AI were cancelled. Meanwhile 78.7 million warrants sit on top of 174.2 million shares.
▲ The constructive case
Money is not the constraint. September liquidity of $774.3 million covers several years even at the third-quarter operating cash pace plus more than $45 million for the new engine line, a calculation. The order book has more than one name: the $50 million Lumilens order, an earlier order above $5 million for Infinity 800G engines, a $2.4 million order from an existing customer, four customers with orders above $1 million each and a first purchase order from another Tier 1 laser manufacturer. Revenue has grown for seven consecutive quarters, and the company has secured about ten times its wafer capacity for 2027.
▼ The cautious case
Third-quarter revenue of $1.03 million compares with an operating loss of $18.8 million, and the 30,000 engines targeted for 2026 now ship by the second quarter of 2027 because of supply shortages and a yield ramp; the new engine line is only targeted to be manufacturing-ready by mid-2027. The net loss was flattered by a $6.4 million non-cash warrant gain. The board shelved the planned U.S. redomicile, the retirement plan for CFO Thomas Mika announced in May was followed on November 2 by the appointment of Giovanni M. Pacelli as his successor, and a securities class action against the company, its CEO and its CFO is pending in New Jersey. A large cash pile can still be spent ahead of demand.
Latest POET Technologies news
Nov 16, 2026
POET Technologies releases unaudited results for period ended September 30, 2026
POET Technologies published unaudited condensed interim financial statements for the three and nine months ended September 30, 2026, approved by its Board on November 16, 2026. Revenue was $1,026,087 for the three months, compared with $298,434 a year earlier, and $2,099,401 for the nine months. The net loss for the three months was $7,560,556, or $(0.04) basic and diluted loss per share. As of September 30, 2026, cash and cash equivalents were $276,018,170 and short-term investments were $498,354,602.
Nov 2, 2026
POET Technologies Names Giovanni Pacelli CFO
POET Technologies appointed Giovanni M. Pacelli as Chief Financial Officer, effective November 2, 2026, succeeding Thomas Mika, who served as CFO for the past ten years. Pacelli was previously Senior Director of Finance at Silicon Labs and brings three decades of financial leadership at public and private companies. Mika will remain with the Company through December 2, 2026 to support the transition. POET will report third-quarter 2026 financial results on Monday, November 16, 2026, and intends to host an earnings conference call each quarter beginning with fourth-quarter and full-year 2026 results.
Oct 2–23, 2026
Shares down about 30% with no operating news
The Nasdaq close fell from $7.79 on October 2 to $5.43 on October 16 and stood at $5.46 on October 23. Over October 2–16, Coherent, Lumentum and Applied Optoelectronics fell about 31%, 24% and 35% on closing prices, a Merlintrader calculation. A sector move is context, not an explanation confirmed by the company.
Oct 16, 2026
Third-quarter results set for November 16
Results for the quarter ended September 30 will be released at 7:00 a.m. ET before the market opens. From the fourth-quarter report, expected March 1, 2027, the company plans regular quarterly conference calls with analysts and investors. That day the shares closed 9.65% lower at $5.43.
Sep 30, 2026
Lead plaintiffs appointed in the securities class action
In Jones v. POET Technologies Inc. (D.N.J., No. 3:26-cv-04717), filed April 28 against the company, CEO Suresh Venkatesan and CFO Thomas Mika, the court appointed Jeremy Byrum and Tan Yong as lead plaintiffs. The case is at an early stage and the allegations have not been proven.
Sep 4, 2026
Optical-industry presentations at IFOC and CIOE
An IFOC presentation on September 8 and CIOE participation on September 9–11. The announcement contains no contract value and no completed qualification.
POET stock catalysts: the dated calendar
- October 31, 2026 — $1 million installment to Sanan for the remaining interest in Super Photonics. Fixed by contract; payment not confirmed by a company release or filing as of November 16, 2026
- November 2, 2026 — Giovanni M. Pacelli appointed Senior Vice President and Chief Financial Officer, effective immediately, succeeding Thomas Mika; 384,615 restricted share units granted. Completed · company release
- November 16, 2026 — Third-quarter results: record revenue of $1,026,087, net loss of $0.04 per share, $774.3 million of cash and short-term investments; the 30,000-engine 2026 target moved into a backlog to ship by the second quarter of 2027. Completed · company release
- December 2, 2026 — Thomas Mika, CFO for the past ten years, stays until this date to support the transition. Company statement
- Fourth quarter of 2026 — Light-source and 800G/1.6T transmitter prototypes. Management target
- Fourth quarter of 2026 — Shipments expected to exceed the total for the first three quarters of 2026; verification of the first Lumilens products, on schedule for this year according to the November 16 release. Company guidance
- First quarter of 2027 — Module-development prototype. Management target
- March 1, 2027 — Fourth-quarter and full-year 2026 results and the first quarterly conference call; first report as a U.S. domestic issuer under U.S. GAAP. Company-announced
- First half of 2027 — Blazar hybrid-laser sampling. Company guidance
- By the second quarter of 2027 — Shipment of the current optical-engine backlog, including the 30,000 engines originally targeted for 2026. Company guidance
- Second quarter of 2027 — Production targets for the light-source and transmitter products. Management target
- Mid-2027 — New engine assembly line in Penang targeted to be manufacturing-ready. Company target
- 2027 — Lumilens production ramp, aligned to hyperscaler deployments; 1.6T engines scheduled to ramp to production; seven of nine active customers expected to enter production with POET engines. Company guidance
- End of 2027 — One million units a month, more than ten times current capacity; second phase of the engine assembly expansion projected complete. Company target
- Early 2028 — Blazar production. Company target
The Lumilens order and the warrant that came with it
| Item | Detail |
|---|---|
| Initial purchase order | $50 million of Optical Interposer-based engines, announced May 14, 2026 |
| Framework | Could exceed $500 million of cumulative purchases over five years; a possible outcome, not backlog |
| Conditions | Successful development and qualification of the modules and scaling of manufacturing capability |
| Timing | First products in assembly development and on schedule for verification in 2026, according to the November 16, 2026 release; production ramp aligned to hyperscaler deployments in 2027 |
| Customer warrant | Up to 22,921,408 shares at $8.25, exercisable over nine years; 2,292,140 vested at September 30, 2026, the rest vesting with cumulative payments toward up to $500 million of orders |
| Accounting | $30.142 million of deferred customer consideration for the vested warrants, amortized as product revenue from the customer is recognized |
Why the order is mainly a 2027 question. With the first products due for verification in late 2026 and a ramp in 2027, most of the $50 million is unlikely to be recognized as revenue in 2026 on the company’s own timetable. That is a Merlintrader inference, not a company statement. Nearer evidence has to come from the earlier 800G engine order and from fourth-quarter shipments, which POET expects to exceed those of the first nine months of 2026 combined. The Lumilens warrants are already inside the 78.7 million total, so adding them again would double-count dilution.
POET products and manufacturing
BACKLOG TO Q2 2027
Optical engines · 800G and 1.6T
Infinity 800G engines carry an order above $5 million. On November 16, 2026 POET said it expects to ship its current engine backlog, including the 30,000 engines originally targeted for 2026, by the second quarter of 2027, and that 1.6T engines are scheduled to ramp to production in 2027. The Lumilens engines use the same interposer platform. A 1.6T 2×DR4 module developed with Lessengers, in which POET holds 4.99%, was targeted for samples in the third quarter.
DEVELOPMENT
Light sources · Blazar
An external light-source engine is in development with a Tier 1 laser company, and an exclusive component arrangement aims to raise the output power of the Blazar hybrid laser. Blazar sampling is expected to begin in the first half of 2027, with production targeted for early 2028. Light-source equipment was being installed at NationGate.
CAPACITY
Penang, Malaysia
A Globetronics cleanroom of about 10,000 square feet holds the wafer-level line, with capacity for one million optical engines a year. A new 15,000-square-foot class 1K clean room has been built for a high-volume engine line, with total investment expected above $45 million and manufacturing readiness targeted for mid-2027. The target of one million units a month by end-2027 is a goal, not installed output.
Merlintrader Health Score · $POET
3.05out of 5
Reassessed on November 16, 2026, after the third-quarter results and the September 30, 2026 financial statements: Execution 2.5 → 2.0 for the postponed 2026 engine target; other pillars unchanged. Weighted calculation: 4.5×30% + 2.5×30% + 2.0×20% + 3.5×10% + 2.0×10% = 1.35 + 0.75 + 0.40 + 0.35 + 0.20 = 3.05; previous score 3.10 (November 14, 2026). The score describes financial and operational robustness over twelve to eighteen months. It is not a rating, a target price or an indication to buy or sell.
Red flags
- September-quarter revenue of $1,026,087 against an operating loss of $18.8 million.
- The largest order is conditional on development, qualification and a 2027 ramp.
- All Celestial AI purchase orders were cancelled in April after Marvell cited confidentiality concerns.
- Shares up by about 41 million in the first half of 2026, with 78.7 million warrants outstanding.
- The 30,000 optical engines targeted for 2026 are now expected to ship by the second quarter of 2027, after supply-chain tightening, wafer and component shortages and a yield ramp; production timing depends on customers qualifying POET engines within their own modules.
- A securities class action against the company, its CEO and its CFO is pending in New Jersey.
- Finance leadership is in transition: Thomas Mika, CFO for the past ten years, whose retirement plan was announced on May 15, was succeeded on November 2, 2026 by Giovanni M. Pacelli, and stays until December 2, 2026 to support the transition.
- PFIC risk for U.S. holders after the redomicile was shelved: the September 30, 2026 MD&A says the company was classified as a PFIC for 2025 and “for the foreseeable future until certain conditions change”, with the status for each year determined after its close.
POET Stock FAQ: POET Technologies Questions Answered
When is the next POET stock catalyst?
POET will report Q4 and full-year 2026 results on March 1, 2027 and host its first quarterly conference call that day. Before then, it expects Q4 shipments to exceed those of the first nine months of 2026 combined, and the first Lumilens products are on schedule for verification this year; the backlog including the 30,000 engines targeted for 2026 is expected to ship by Q2 2027. Details. Supporting document.
How much revenue does POET Technologies make?
POET reported record revenue of $1,026,087 for the quarter ended September 30, 2026, up 80% from $569,925 in the June quarter and 244% from a year earlier, its seventh consecutive quarter of sequential growth. Nine-month revenue was $2.10 million. The September-quarter operating loss was $18.8 million; announced orders differ from revenue recognized after qualification and delivery. Details. Supporting document.
How much cash does POET have, and how long will it last?
POET reported $276.0 million of cash and equivalents and $498.4 million of short-term investments at September 30, 2026, $774.3 million in total. A $31.1 million strategic loan receivable and a $3.0 million investment in a supplier are separate assets. Third-quarter operating cash use was $12.7 million, and the new engine line is expected to cost more than $45 million; historical spending is not a fixed runway. Details. Supporting document.
Is POET stock at risk of dilution?
Yes: POET reported 174,215,937 common shares and 78,729,968 warrants at September 30 and November 16, 2026, including the Lumilens customer warrants, of which 2,292,140 had vested. In the September 30 warrant table, warrants for 9,346,798 shares carry exercise prices from $1.09 to $5.00 and the rest range up to $26.25. Exercises and other issuance can expand the share count. Details. Supporting document.
When does POET Technologies report earnings?
POET reported Q3 2026 results on November 16, 2026. It will report Q4 and full-year 2026 results on March 1, 2027 and host its first quarterly conference call that day; from that report it will file as a U.S. domestic issuer, with financial statements under U.S. GAAP. Details.
What does POET Technologies do?
POET Technologies designs optical engines, light sources and modules for AI systems and data centers, built on its Optical Interposer platform. Revenue is still small, a record $1,026,087 in the quarter ended September 30, 2026, as the company moves from customer qualification toward volume manufacturing. Details.
Is POET’s Lumilens agreement already revenue?
No: POET’s May 14, 2026 announcement describes an initial $50 million order within a relationship that could exceed $500 million over five years. Revenue depends on successful development, qualification and manufacturing scale. On November 16, 2026 POET said the first Lumilens products were in assembly development and on schedule for verification this year, with the production ramp aligned to 2027. Details.
Primary sources
- Record third-quarter 2026 revenue, capacity update and outlook, November 16, 2026
- SEC Form 6-K, Exhibit 99.1: third-quarter 2026 results release, November 16, 2026
- Unaudited financial statements, nine months ended September 30, 2026 (Form 6-K, Exhibit 99.1)
- Management discussion and analysis, September 30, 2026 (Form 6-K, Exhibit 99.2)
- Giovanni M. Pacelli named Chief Financial Officer, succeeding Thomas Mika, and restricted share unit grant, November 2, 2026
- SEC Form 6-K, Exhibit 99.1: CFO appointment release, November 2, 2026
- Unaudited financial statements, six months ended June 30, 2026
- Management discussion and analysis, June 30, 2026
- Second-quarter results and commercial developments, August 13, 2026
- Third-quarter results date, October 16, 2026
- Lumilens supply agreement, purchase order and warrant, May 14, 2026
- Company FAQ on production orders and qualification, July 14, 2026
- US$400 million financing and CFO retirement plan, May 15, 2026
- Celestial AI purchase-order cancellation, April 27, 2026
- Securities class action against POET Technologies Inc., No. 3:26-cv-04717 (D.N.J.)
- Nasdaq short-interest table (settlement date October 30, 2026)
Disclaimer. This content is published by Merlintrader for educational and informational purposes only. It is independent journalism and research. It does not constitute investment advice, an investment recommendation, an offer or a solicitation to buy or sell any security, and it is not a research report within the meaning of applicable United States securities regulation. Nothing here should be read as a recommendation to buy, sell or hold $POET or any other security.
Figures are taken from public filings with the U.S. Securities and Exchange Commission, company press releases, court records and market-data providers, and are stated with their reference dates. Data can change without notice. Readers should verify every figure against the primary source before acting on it.
Small and mid-cap technology companies carry high execution risk. Products fail qualification, customers cancel or delay orders, manufacturing yields disappoint, and companies that spend ahead of revenue frequently raise equity at whatever price the market will bear. This company reported quarterly revenue of about $1 million against an operating loss of about $19 million in the September 2026 quarter, has 78.7 million warrants outstanding and is a defendant in a pending securities class action. Every reader is responsible for their own decisions and should consult a licensed financial adviser where appropriate.
Merlintrader may hold positions in securities mentioned. Some links on this page are affiliate or referral links, including those to Finviz, which may generate a commission at no cost to the reader. Full legal information is available on the disclaimer and terms of use and privacy pages.



